LINC01500

Across TCGA pan-cancer cohorts, LINC01500 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01500’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01500 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01500 is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

LUAD, BRCA, and ESCA are the cancer types where LINC01500 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01500 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.148	<.001	5	view →
BRCA	All	II,III,IV	+0.064	<.001	4	view →
ESCA	All	II,III,IV	+0.155	.043	2	view →
KIRP	All	All	+0.114	.014	2	view →
BLCA	All	III,IV	−0.083	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01500–LUAD

Open the LUAD breakdown →